- Home
- A-Z Publications
- Current Pharmaceutical Design
- Previous Issues
- Volume 14, Issue 7, 2008
Current Pharmaceutical Design - Volume 14, Issue 7, 2008
Volume 14, Issue 7, 2008
-
-
Editorial [ Carbonic Anhydrases as Drug Targets Executive Editor: Claudiu T. Supuran ]
More LessCarbonic anhydrases (CAs), the metalloenzymes that catalyze the conversion between carbon dioxide and bicarbonate, continue to be surprising targets, as many exciting new discoveries related to them emerge constantly. This is indeed unprecedented as these are quite “old” enzymes, which were discovered in 1933, and thoroughly investigated since then as drug targets. Furthermore, their inhibitors are in clinical use si Read More
-
-
-
Carbonic Anhydrases - An Overview
More LessCarbonic anhydrases (CAs, EC 4.2.1.1) are widespread metalloenzymes all over the phylogenetic tree, with at least 4 distinct gene families encoding for them. At least 16 different α- CA isoforms were isolated in mammals, where these enzymes play crucial physiological roles. Representatives of the β - δ-CA family are highly abundant in plants, diatoms, eubacteria and archaea. These enzymes are efficient cata Read More
-
-
-
Design of Zinc Binding Functions for Carbonic Anhydrase Inhibitors
Authors: Jean-Yves Winum, Andrea Scozzafava, Jean-Louis Montero and Claudiu T. SupuranZinc ion plays a crucial role in the protein's functions and is linked to a variety of physiological processes. It constitutes an essential component of numerous enzymes especially carbonic anhydrase (CAs, EC 4.2.1.1), a pharmaceutically-important metalloprotein which catalyses efficiently the reversible hydration of carbon dioxide to bicarbonate with discharge of a proton. The potential therapeutic applications of selective carb Read More
-
-
-
The α and β Classes Carbonic Anhydrases from Helicobacter pylori as Novel Drug Targets
Authors: Isao Nishimori, Saburo Onishi, Hiroaki Takeuchi and Claudiu T. SupuranHelicobacter pylori (H. pylori) successfully resides in the human stomach in highly acidic conditions, causing a variety of gastroduodenal lesions, including gastric ulcer, gastric cancer and MALT lymphoma. For acid acclimation of H. pylori, two types of enzymes, urease and carbonic anhydrase (CA), play a central role. They cooperatively function to maintain neutral pH in the bacterial cytoplasm and periplasm. The genome proj Read More
-
-
-
The Alpha-Carbonic Anhydrase from the Malaria Parasite and its Inhibition
Authors: Jerapan Krungkrai and Claudiu T. SupuranPlasmodium falciparum is the protozoan parasite responsible for the majority of life-threatening cases of human malaria, causing more than one million deaths a year. The global emergence of drug-resistant malarial parasites necessitates identification and characterization of novel drug targets. At present, α-carbonic anhydrase (CA) genes are identified in limited numbers of parasites in both protozoa and helminthes, ho Read More
-
-
-
Diuretics: From Classical Carbonic Anhydrase Inhibitors to Novel Applications of the Sulfonamides
More LessThe widely clinically used benzothiadiazines and high ceiling diuretics, such as hydrochlorothiazide, hydroflumethiazide, quinethazone, metolazone, chlorthalidone, indapamide, furosemide and bumetanide, contain SO2NH2 moieties acting as an effective zincbinding function in carbonic anhydrases (CAs, EC 4.2.1.1) inhibitors. These drugs were launched in a period when only isoform CA II was known and considered physi Read More
-
-
-
The Development of Topically Acting Carbonic Anhydrase Inhibitors as Antiglaucoma Agents
Authors: Francesco Mincione, Andrea Scozzafava and Claudiu T. SupuranInhibition of carbonic anhydrase (CA, EC 4.2.1.1) isoforms present in the eyes (CA I, II, IV and XII), with sulfonamides such as acetazolamide, methazolamide, ethoxzolamide and dichlorophenamide, is still widely used for the systemic treatment of glaucoma. The mechanism of action of these drugs consists in inhibition of CA isozymes present in ciliary processes of the eye, with the consequent reduction of bicarbonate an Read More
-
-
-
Are Carbonic Anhydrase Inhibitors Suitable for Obtaining Antiobesity Drugs ?
Authors: Giuseppina D. Simone, Anna Di Fiore and Claudiu T. SupuranObesity is widespread disease both in the developed and developing world, which currently affects over 300 million individuals worldwide and is associated with premature mortality and chronic morbidity. Although diet, physical activity and behavioral modifications should theoretically help in controlling this condition, very often these strategies are insufficient to normalize the multiple risks associated with this condition. Thus, Read More
-
-
-
Anticonvulsant Sulfonamides/Sulfamates/Sulfamides with Carbonic Anhydrase Inhibitory Activity: Drug Design and Mechanism of Action
Authors: Anne Thiry, Jean-Michel Dogne, Claudiu T. Supuran and Bernard MasereelThe marketed antiepileptic drugs can not solve entirely the problem of seizure in patients suffering from refractory epilepsies. Therefore, new anticonvulsant compounds structurally and pharmacologically different of the currently prescribed drugs are needed. Carbonic anhydrase (CA) inhibitors are known to act as anticonvulsant since several decades while the link between CA and seizure is not straightforward. Howev Read More
-
-
-
Recent Advances in Research on the Most Novel Carbonic Anhydrases,CA XIII and XV
Authors: M. Hilvo, A. Innocenti, S. M. Monti, G. D. Simone, C. T. Supuran and S. ParkkilaThe carbonic anhydrase (CA) enzyme family consists of thirteen active isozymes in mammals. The most recently characterized members of this family are cytosolic CA XIII and membrane-bound CA XV. This article describes recent advances in the CA family, especially CA XIII and XV. We have also included catalytic activity data on human CA XIII and mouse CA XV. Additionally, the inhibition constants of acetazolamide toward th Read More
-
-
-
Carbonic Anhydrase Inhibition: Insight into Non-COX-2 Pharmacological Effect of some Coxibs
Authors: Jean-Michel Dogne, Anne Thiry and Claudiu T. SupuranNonsteroidal anti-inflammatory drugs (NSAIDs) represent the most commonly used medications for the treatment of pain and inflammation, but numerous well-described adverse drug reactions (ADRs) limit their use. These drugs act via the inhibition of cyclooxygenase (COX) enzyme of which at least two isoforms were described: COX-1 which plays important roles in homeostatic processes such as thrombogenesis and homeos Read More
-
-
-
Cancer-Associated Carbonic Anhydrases and Their Inhibition
Authors: S. Pastorekova, M. Zatovicova and J. PastorekCells of the growing tumor tissue are exposed to physiological stresses connected with insufficient delivery of oxygen (hypoxia) and accumulation of acidic products of the glycolytic metabolism (acidosis). Adaptation to these microenvironmental stresses involves remodeling of the cellular expression program mediated by hypoxia-inducible factor (HIF), which activates broad array of genes functionally involved in angiogene Read More
-
-
-
Fluorescence- and Spin-Labeled Carbonic Anhydrase Inhibitors
Authors: Alessandro Cecchi and Claudiu T. SupuranCarbonic anhydrase IX (hCA IX) is a membrane-associated glycoprotein that is observed in many tumor tissues and is strongly overexpressed by hypoxia conditions. Hypoxia is a clinically important tumor parameter and this enzyme can play an important role as a potential marker of hypoxic tumor and as a therapeutic target too. In the last years, Carbonic Anhydrase IX Inhibitors which possess fluorescent probe were largely Read More
-
-
-
Carbonic Anhydrase Activation and the Drug Design
Authors: Claudia Temperini, Andrea Scozzafava and Claudiu T. SupuranThe activation mechanism of Carbonic Anhydrase was recently explained using kinetic, spectroscopic and X-ray techniques. It has been demonstrated that the activators molecules (CAAs) bind at the entrance of the enzyme active-site facilitating the ratedetermining step of CA catalitic cycle. Drug design studies have been performed in order to obtain strong CAAs belonging to several chemical classes: amino ac Read More
-
-
-
The β and γ Classes of Carbonic Anhydrase
Authors: S. A. Zimmerman and J. G. FerryThere are currently five (α,β,γ,δ,Ezgr;) classes of carbonic anhydrases (CA's) of which the α-class from mammalian sources has been studied to a much greater extent compared to the other four classes. Yet, CA's other than the α-class are widely distributed in Nature and play important roles in human health, the global carbon cycle, and industrial applications. In aerobic prokaryotes, β-class CA's are implicated in maintaining i Read More
-
Volumes & issues
-
Volume 31 (2025)
-
Volume 30 (2024)
-
Volume 29 (2023)
-
Volume 28 (2022)
-
Volume 27 (2021)
-
Volume 26 (2020)
-
Volume 25 (2019)
-
Volume 24 (2018)
-
Volume 23 (2017)
-
Volume 22 (2016)
-
Volume 21 (2015)
-
Volume 20 (2014)
-
Volume 19 (2013)
-
Volume 18 (2012)
-
Volume 17 (2011)
-
Volume 16 (2010)
-
Volume 15 (2009)
-
Volume 14 (2008)
- Issue 36
- Issue 35
- Issue 34
- Issue 33
- Issue 32
- Issue 31
- Issue 30
- Issue 29
- Issue 28
- Issue 27
- Issue 26
- Issue 25
- Issue 24
- Issue 23
- Issue 22
- Issue 21
- Issue 20
- Issue 19
- Issue 18
- Issue 17
- Issue 16
- Issue 15
- Issue 14
- Issue 13
- Issue 12
- Issue 11
- Issue 10
- Issue 9
- Issue 8
- Issue 7
- Issue 6
- Issue 5
- Issue 4
- Issue 3
- Issue 2
- Issue 1
-
Volume 13 (2007)
-
Volume 12 (2006)
-
Volume 11 (2005)
-
Volume 10 (2004)
-
Volume 9 (2003)
-
Volume 8 (2002)
-
Volume 7 (2001)
-
Volume 6 (2000)
Most Read This Month
Article
content/journals/cpd
Journal
10
5
false
en
